1. Factors affecting upper airway control of NSAID‐exacerbated respiratory disease: A real‐world study of 167 patients
- Author
-
Johanna Sahlman, Anu Laulajainen-Hongisto, Paula Kauppi, Jyri Myller, Seija Vento, Annina Lyly, Sanna Toppila-Salmi, Jura Numminen, Heikki Turpeinen, Saara Sillanpää, Tampere University, Department of Otology and Oral Diseases, Clinical Medicine, Clinicum, HUS Inflammation Center, Department of Dermatology, Allergology and Venereology, University of Helsinki, Helsinki University Hospital Area, HUS Head and Neck Center, Korva-, nenä- ja kurkkutautien klinikka, HYKS erva, Päijät-Häme Welfare Consortium, Department of Pathology, and Medicum
- Subjects
lcsh:Immunologic diseases. Allergy ,0301 basic medicine ,N-ERD ,disease control ,N‐ERD ,medicine.medical_specialty ,Immunology ,CHRONIC RHINOSINUSITIS ,03 medical and health sciences ,0302 clinical medicine ,CLINICAL CHARACTERISTICS ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,Eosinophilia ,Nasal polyps ,Prospective Studies ,3125 Otorhinolaryngology, ophthalmology ,Airway Management ,RECURRENCE ,Prospective cohort study ,Retrospective Studies ,Rhinitis ,Original Research ,Asthma ,nasal polyps ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,Hazard ratio ,Ethmoidectomy ,Odds ratio ,asthma ,medicine.disease ,Confidence interval ,PREVALENCE ,3. Good health ,ASPIRIN ,REVISION RATES ,030104 developmental biology ,3121 General medicine, internal medicine and other clinical medicine ,medicine.symptom ,lcsh:RC581-607 ,business ,ENDOSCOPIC SINUS SURGERY ,eosinophilia ,CRS ,030215 immunology - Abstract
Background Nonsteroidal anti‐inflammatory drug (NSAID) exacerbated respiratory disease (N‐ERD) is a triad with asthma, chronic rhinosinusitis with nasal polyps, and NSAID intolerance. Uncontrolled N‐ERD forms a major public health problem due to frequent and difficult‐to‐treat exacerbations and/or requiring putatively frequent endoscopic sinus surgeries (ESS). Our aim was to study factors affecting control of N‐ERD. Methods Retrospective patient record data (patient characteristics, prior sinus surgeries, follow‐up data in 2020) from 167 N‐ERD patients undergoing consultation at three tertiary hospitals from 2001 to 2017 was used. Outcome measurements reflecting uncontrolled N‐ERD were revision ESS, corticosteroids/biological therapy, and antibiotic courses during 2016–2020. Associations were analyzed by using nonparametric tests, Cox's proportional hazard, and binary logistic regression models. Results Nasal polyp eosinophilia increased the risk of revision surgery during the follow‐up (adjusted hazard ratio [aHR] 3.21, confidence interval 1.23–8.38). Also baseline oral corticosteroids (OCS; HR, 1.73, 1.04–2.89) and baseline surgery without total ethmoidectomy increased the risk of revision ESS (HR, 2.17, 1.07–4.42) in unadjusted models. In addition, both baseline OCS (adjusted odds ratio [aOR] 2.78, 1.23–6.26) and a history of ≥4 previous ESS (aOR, 2.15, 0.98–4.70) were associated with the use of OCS/biological therapy during the follow‐up, but not with high number of antibiotics. Conclusions Nasal polyp eosinophilia, baseline OCS, and a history of recurrent ESS predict uncontrolled N‐ERD. These factors might be clinically useful in risk‐estimation of uncontrolled disease and for organizing follow‐ups. Prospective cohort studies with larger sample size are needed to further study the factors affecting the upper airway control of N‐ERD., The patient record data of 167 patients with NSAID‐exacerbated respiratory disease was analyzed to study factors affecting the disease control. Nasal polyp eosinophilia increased the risk of revision surgery, and baseline oral corticosteroids and a history of four or more endoscopic sinus surgeries were associated with poor disease control during the follow‐up.
- Published
- 2021